Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:48 AM
Ignite Modification Date:
2025-12-26 @ 11:48 AM
NCT ID:
NCT00541216
Eligibility Criteria:
Inclusion Criteria:
* Male or female patients , with congenital myasthenia, belonging to a previously reported kindred diagnosed with COLQ deficiency.
Exclusion Criteria:
* History of allergy to Ephedrine or any inactive component.
* Significant abnormalities in screening Cardiovascular parameters (blood pressure, pulse).
* Surgery within 6 weeks of screening.
* Concurrent use of any other medication except steroids.
* Pregnancy.
* Thyrotoxicosis.
* Co-morbid conditions or other neurological disorders that would confound assessment of clinical parameters.
* Participation in another clinical trial within 30 days of study start.
* Patients who are non-cooperative or parents/ legal guardians who are unwilling to sign consent form.
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
75 Years
Study:
NCT00541216
Study Brief:
Protocol Section:
NCT00541216